课题基金 / 基金详情

Nonpayment for Preventable Complications: Impact on Hospital Practices and Health

Nonpayment for Preventable Complications: Impact on Hospital Practices and Health
可预防并发症不付款:对医院实践和健康的影响
批准号:
7897759
负责人:
Grace M Lee
金额:
$19.42万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-22 至 2011-06-30

项目摘要

项目成果

Grace M Lee的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):财务激励措施,如按绩效付费(P4P)计划,越来越多地用于改善医生的行为。然而,这些计划对改善患者护理质量的影响好坏参半,一些研究显示出适度的收益,另一些研究报告称护理质量措施几乎没有改善。此外,P4P计划的意外后果已经得到证明,包括对那些在基线上表现更好的医院的更大的经济奖励,以及为大量少数民族人口服务的医院的重大经济损失。从2008年10月1日起,医疗保险将实施一种新的财务机制--可预防并发症不付款(NPPC)--这是一种“大棒”而不是“胡萝卜”。医疗保险将不再支付医院治疗某些医疗保健相关感染(HAI)的费用,这些感染发生在患者入院时不在场的情况下。我们提出的研究是独特和及时的。目前还没有关于美国最大的支付者之一正在实施的NPPC政策干预的影响的数据。尽管缺乏证据证明其有效性,但人们希望财政抑制措施将激励医院和供应商集中精力减少HAI。虽然这一目标当然是有价值的,但应严格评估用于推动变革的机制,以确保它实现预期的结果,而不会出现意外的后果。我们的研究将提供对NPPC对患者护理和结果的潜在影响的丰富理解,无论是积极的还是消极的。本提案的长期目标是评估NPPC对患者护理和结局的总体影响。在这两个阶段的研究中,我们将首先进行定性访谈,以确定可能影响医院做法和HAI率的关键因素。在第二阶段,我们将根据我们的定性研究结果开发,试点和验证调查工具,以便在未来对感染预防人员进行调查,以评估NPPC对美国医院的影响。确定可能影响NPPC背景下感染预防实践的关键因素。2.开发、试验和验证一种调查工具,以检查NPPC对医院行为和实践的感知影响。公共卫生相关性:美国医院每年发生约170万至200万例医疗相关感染(HAI)和99,000例HAI死亡。HAI的经济负担估计为每年170亿至290亿美元。我们拟议的研究将提供有关医疗保险对可预防并发症的不支付(即减少与HAI相关的住院报销)对护理质量和健康结果的影响的关键信息。
英文摘要
DESCRIPTION (provided by applicant): Financial incentives, such as pay-for-performance (P4P) programs, are increasingly being used to improve physician behavior. However, the impact of these programs on improving quality of care for patients have been mixed, with some studies showing modest gains and others reporting little to no improvement on quality of care measures. Furthermore, unintended consequences of P4P programs have been demonstrated, including larger financial rewards for those hospitals with higher performance at baseline and significant financial losses for hospitals that serve large minority populations. As of October 1, 2008, Medicare will implement the use of a new financial mechanism-nonpayment for preventable complications (NPPC)-which is a "stick" rather than a "carrot". Medicare will no longer pay hospitals for treating certain healthcare associated infections (HAIs) that arise in patients if they are not present on admission. Our proposed research is unique and timely. There are no data available on the impact of a NPPC policy intervention that is being implemented by one of the largest payers in the U.S. Despite lack of evidence for its efficacy, it is hoped that financial disincentives will motivate hospitals and providers to focus their efforts on reducing HAIs. While the goal is certainly worthy, the mechanism being used to motivate change should be rigorously evaluated to ensure that it achieves its intended consequences without the occurrence of unintended consequences. Our research will provide a rich understanding of the potential impact, both positive and negative, of NPPC on patient care and outcomes. The long-term goal of this proposal is to assess the overall impact NPPC on patient care and outcomes. In this two-phase study, we will first conduct qualitative interviews to identify key elements that may affect hospital practices and rates of HAIs. In the second phase, we will develop, pilot, and validate a survey instrument based on our qualitative research findings in order to conduct a future survey of infection preventionists to assess the perceived impact of NPPC on hospitals in the U.S. Thus, we propose the following specific aims: 1. To identify key factors that may affect infection prevention practices in the context of NPPC. 2. To develop, pilot, and validate a survey instrument to examine the perceived impact of NPPC on behaviors and practices in hospitals. PUBLIC HEALTH RELEVANCE: Approximately 1.7 to 2 million healthcare-associated infections (HAIs) and 99,000 deaths due to HAIs occur in U.S. hospitals annually. The economic burden of HAIs is estimated at $17 to $29 billion dollars each year. Our proposed study will provide crucial information regarding the impact of Medicare's use of nonpayment for preventable complications (i.e. reduced reimbursement for hospitalizations associated with HAIs) on quality of care and health outcomes.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.7257/1053-816x.2013.33.1.15
发表时间: 2013
期刊: Urologic nursing
影响因子: --
作者: [J. Palmer;Grace Lee;M. Dutta-Linn;Peter C. Wroe;C. Hartmann]
通讯作者: J. Palmer;Grace Lee;M. Dutta-Linn;Peter C. Wroe;C. Hartmann
DOI: 10.1177/1077558711413606
发表时间: 2012-02
期刊: Medical care research and review : MCRR
影响因子: --
作者: [Hartmann CW, Hoff T, Palmer JA, Wroe P, Dutta-Linn MM, Lee G]
通讯作者: Lee G
Making the CMS Payment Policy for Healthcare‐Associated Infections Work: Organizational Factors That Matter
使针对医疗保健相关感染的 CMS 支付政策发挥作用:重要的组织因素
DOI: 10.1097/00115514-201109000-00007
发表时间: 2011
期刊: Journal of Healthcare Management
影响因子: 1.8
作者: [T. Hoff, C. Hartmann, Christina Soerensen, M. Dutta, Grace Lee]
通讯作者: Grace Lee
Defining and Preventing Ventilator-Associated Complications in Pediatrics
Defining and Preventing Ventilator-Associated Complications in Pediatrics
Defining and Preventing Ventilator-Associated Complications in Pediatrics
Nonpayment for Preventable Complications: Impact on Hospital Practices and Health
海外基金